Hong Kong Stocks End Week Higher; Hengrui Pharma, Mirxes Surge in Debut

MT Newswires Live

May 23

Hong Kong stocks rose slightly on Friday to close the week in green, buoyed by multiple strong market debuts.

The Hang Seng Index edged up 0.2%, or 56.95 points, to end at 23,601.26. The Hang Seng China Enterprises Index rose 0.3%, or 26.22 points, to 8,583.86.

Two firms saw a stellar trading debut on the Hong Kong bourse on Friday.

Singapore-headquartered micro ribonucleic acid technology company Mirxes Holding (HKG:2629) finished at HK$30 per share, up almost 29% from its IPO price of HK$23.30.

Jiangsu Hengrui Pharmaceuticals (HKG:1276, SHA:600276) closed at HK$55.15 per share, up 25% from its IPO price of HK$44.05.

Earlier this week, CATL (HKG:3750, SHE:300750) also made a strong market debut. The battery giant raised over HK$35 billion from its Hong Kong IPO, reportedly the world's largest listing so far this year, according to Reuters.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2537518576"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2537518576\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2537518576?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-23 16:48","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2537518576","market":"sg","top_or_hot":-1,"title":"Hong Kong Stocks End Week Higher; Hengrui Pharma, Mirxes Surge in Debut","media":"MT Newswires Live","content":"<html><body><p> Hong Kong stocks rose slightly on Friday to close the week in green, buoyed by multiple strong market debuts.</p><p>The Hang Seng Index edged up 0.2%, or 56.95 points, to end at 23,601.26. The Hang Seng China Enterprises Index rose 0.3%, or 26.22 points, to 8,583.86.</p><p>Two firms saw a stellar trading debut on the Hong Kong bourse on Friday.</p><p>Singapore-headquartered micro ribonucleic acid technology company Mirxes Holding (HKG:2629) finished at HK$30 per share, up almost 29% from its IPO price of HK$23.30.</p><p>Jiangsu Hengrui Pharmaceuticals (HKG:1276, SHA:600276) closed at HK$55.15 per share, up 25% from its IPO price of HK$44.05.</p><p>Earlier this week, CATL (HKG:3750, SHE:300750) also made a strong market debut. The battery giant raised over HK$35 billion from its Hong Kong IPO, reportedly the world's largest listing so far this year, according to Reuters.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hong Kong Stocks End Week Higher; Hengrui Pharma, Mirxes Surge in Debut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHong Kong Stocks End Week Higher; Hengrui Pharma, Mirxes Surge in Debut\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-05-23 16:48</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Hong Kong stocks rose slightly on Friday to close the week in green, buoyed by multiple strong market debuts.</p><p>The Hang Seng Index edged up 0.2%, or 56.95 points, to end at 23,601.26. The Hang Seng China Enterprises Index rose 0.3%, or 26.22 points, to 8,583.86.</p><p>Two firms saw a stellar trading debut on the Hong Kong bourse on Friday.</p><p>Singapore-headquartered micro ribonucleic acid technology company Mirxes Holding (HKG:2629) finished at HK$30 per share, up almost 29% from its IPO price of HK$23.30.</p><p>Jiangsu Hengrui Pharmaceuticals (HKG:1276, SHA:600276) closed at HK$55.15 per share, up 25% from its IPO price of HK$44.05.</p><p>Earlier this week, CATL (HKG:3750, SHE:300750) also made a strong market debut. The battery giant raised over HK$35 billion from its Hong Kong IPO, reportedly the world's largest listing so far this year, according to Reuters.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU2242644610.SGD","symbol_name":"Fidelity China Innovation A-ACC-SGD","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2537518576","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2537518576","pubTimestamp":1747990101,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Hong Kong stocks rose slightly on Friday to close the week in green, buoyed by multiple strong market debuts.The Hang Seng Index edged up 0.2%, or 56.95 points, to end at 23,601.26. The Hang Seng China Enterprises Index rose 0.3%, or 26.22 points, to 8,583.86.Two firms saw a stellar trading debut on the Hong Kong bourse on Friday.Singapore-headquartered micro ribonucleic acid technology company Mirxes Holding  finished at HK$30 per share, up almost 29% from its IPO price of HK$23.30.Jiangsu Hengrui Pharmaceuticals  closed at HK$55.15 per share, up 25% from its IPO price of HK$44.05.Earlier this week, CATL  also made a strong market debut. The battery giant raised over HK$35 billion from its Hong Kong IPO, reportedly the world's largest listing so far this year, according to Reuters.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"513600":"恒生指数ETF","600276":"恒瑞医药","LU2242644610.SGD":"Fidelity China Innovation A-ACC-SGD","LU1051769294.HKD":"BGF EMERGING MARKETS EQUITY INCOME \"A6\"(HKDHDG) INC","HSI":"恒生指数","LU1880383366.USD":"东方汇理中国股票基金 A2 (C)","02833":"恒指ETF","LU0359201612.USD":"贝莱德中国基金A2","LU1580142542.USD":"Blackrock Systematic China A-Share Opportunities A2 USD","LU0455707207.USD":"FIDELITY FUNDS  CHINA INNOVATION \"A\" (USD) INC","LU1997245177.USD":"安联神洲A股基金","LU1023057109.AUD":"BGF CHINA \"A2\" (AUDHDG) ACC","LU0348805143.USD":"ALLIANZ ENHANCED ALL CHINA EQUITY \"A\" (USD) INC","LU2580892789.USD":"FRANKLIN SEALAND CHINA A-SHARES \"A\" (USD) ACC","BK0183":"MSCI概念","IE00B543WZ88.USD":"NEUBERGER BERMAN CHINA EQUITY \"A\" (USD) ACC","LU0449509016.USD":"HSBC GIF BRIC EQUITY \"AC\" (USD) ACC","BK0188":"融资融券","LU2153591404.USD":"Aberdeen Standard SICAV I - Asian Sustainable Development Equity A Acc USD","LU1781817850.SGD":"Blackrock Systematic China A-Share Opportunities A2 SGD-H","LU0516423091.SGD":"FULLERTON LUX FUNDS - ASIA FOCUS EQUITIES \"I\" (SGD) ACC","LU2097828557.USD":"AZ EQUITY CHINA \"A\" (USD) ACC","LU0128522157.USD":"TEMPLETON ASIAN GROWTH \"A\" ACC","LU0164865239.USD":"HSBC GIF CHINESE EQUITY \"AC\" (USD) ACC","LU2778985437.USD":"ALLIANZ CHINA FUTURE TECHNOLOGIES \"A\" (USD) INC","EVS.SI":"MSCI China Electric Vehicles and Future Mobility ETF-NikkoAM","LU0823414478.USD":"法巴经典能源转换基金","LU2039709279.SGD":"MANULIFE GF DRAGON GROWTH \"AA\" (SGDHDG) INC","LU1769817096.USD":"UBS (LUX) EQUITY SICAV - GLOBAL EMERG MARKETS OPPO \"P\" (USD) INC","LU1813983027.USD":"MANULIFE GF DRAGON GROWTH \"AA\" (USD) INC","LU2476274720.SGD":"ALLIANZ CHINA FUTURE TECHNOLOGIES \"AT\" (SGDHDG) ACC","BK0060":"抗癌","LU2298064838.USD":"NINETY ONE GSF GLOBAL ENVIRONMENT \"A\" (USD) INC","LU1969619763.USD":"EASTSPRING INV CHINA A SHARES GROWTH \"A\" (USD) ACC","LU1979443071.USD":"AB CHINA A SHARES EQUITY PORTFOLIO \"AD\" (USDHDG) INC","LU1064131003.USD":"FULLERTON LUX FUNDS - CHINA A EQUITIES \"A\" (USD) ACC","SG9999001846.SGD":"Schroder Asian Equity Yield A Dis SGD","01276":"恒瑞医药","LU0607220059.USD":"SCHRODER ISF HONG KONG EQUITY \"A\" (USD) ACC","IE0003851619.USD":"BNY MELLON ASIAN EQUITY \"B\" (USD) ACC","02629":"MIRXES-B","LU0106252389.USD":"SCHRODER ISF EMERGING MARKETS \"A\" ACC","LU0047713382.USD":"BGF EMERGING MARKETS \"A2\" ACC","LU2148510915.USD":"FULLERTON LUX FUNDS - CHINA A EQUITIES \"R\" (USD) ACC","IE00BPRC5H50.USD":"NEUBERGER BERMAN CHINA EQUITY \"A\" (USD) INC"},"translate_title":"港股本周收高；恒瑞医药、Mirxes首发大涨","themeId":"92258637d6ff1e9cb4f4844790de8572","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"513600":0.6,"600276":0.9,"01276":0.9,"02629":1,"02833":0.6,"EVS.SI":0.6,"HHImain":0.6,"MCHmain":0.6,"MHImain":0.6,"HSI":0.9},"content_text":"Hong Kong stocks rose slightly on Friday to close the week in green, buoyed by multiple strong market debuts.The Hang Seng Index edged up 0.2%, or 56.95 points, to end at 23,601.26. The Hang Seng China Enterprises Index rose 0.3%, or 26.22 points, to 8,583.86.Two firms saw a stellar trading debut on the Hong Kong bourse on Friday.Singapore-headquartered micro ribonucleic acid technology company Mirxes Holding (HKG:2629) finished at HK$30 per share, up almost 29% from its IPO price of HK$23.30.Jiangsu Hengrui Pharmaceuticals (HKG:1276, SHA:600276) closed at HK$55.15 per share, up 25% from its IPO price of HK$44.05.Earlier this week, CATL (HKG:3750, SHE:300750) also made a strong market debut. The battery giant raised over HK$35 billion from its Hong Kong IPO, reportedly the world's largest listing so far this year, according to Reuters.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}